A Comprehensive Review of Natural and Synthetic Flavonoids as Antibiofilm Agents Against Bacterial Biofilms

Samyuktha Arimalai Dinakararaja1, Ethiraj Kannatt Radhakrishnan2

  • 1Department of Chemistry, School of Advanced Sciences, Vellore Institute of Technology, Vellore, 632014, India.

Current Microbiology
|July 30, 2026
PubMed

Insights

Flavonoids show promise in combating antibiotic resistance by inhibiting bacterial biofilms. This review explores natural and synthetic flavonoids, highlighting their potential as antibiofilm agents for future drug development.

Area of Science:

  • Microbiology and Pharmacology
  • Natural Product Chemistry
  • Drug Discovery

Background:

  • Bacterial biofilms contribute significantly to antimicrobial resistance by shielding bacteria from antibiotics and immune defenses.
  • Understanding biofilm formation and resistance mechanisms is crucial for developing effective therapeutic strategies.

Purpose of the Study:

  • To systematically review recent advancements in natural and synthetic flavonoids as antibiofilm agents.
  • To critically evaluate the potential of flavonoids against clinically relevant bacterial biofilms.
  • To explore structure-activity relationships and antibiofilm mechanisms of flavonoid derivatives.

Main Methods:

  • Comprehensive literature review of natural and synthetic flavonoids targeting bacterial biofilms.
  • Analysis of studies focusing on biofilm inhibition, disruption, and quorum sensing interference.
  • Evaluation of synthetic strategies and structure-activity relationships for improved flavonoid efficacy.

Main Results:

  • Plant-derived flavonoids demonstrate significant antibiofilm activity, inhibiting formation and disrupting mature biofilms.
  • Synthetic flavonoid analogues, including flavones and flavanones, show promising structure-activity relationships and diverse antibiofilm mechanisms.
  • Recent synthetic strategies enhance flavonoid potency, selectivity, and pharmacokinetic properties.

Conclusions:

  • Flavonoids represent versatile scaffolds for developing novel antibiofilm agents.
  • Further research is needed to address limitations in in-vivo translation and clinical advancement.
  • Targeted drug development strategies are essential for realizing the full clinical potential of flavonoids against biofilms.